Sildenafil in erectile dysfunction: a critical review
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Sildenafil citrate (Viagra) is a potent orally active cGMP-specific phosphodiesterase type 5 (PDE5) inhibitor that is effective as a peripheral conditioner in the treatment of male erectile dysfunction (ED) of organic, psychogenic or mixed aetiology. Sildenafil is the first effective oral agent in the management of ED that has had a revolutionary impact on management of ED. The present review has been subdivided into five major sections. Based on the most recent peer-reviewed publications, the first section is aimed at critically evaluating PDE5 selectivity as well as the pharmacokinetics and pharmacodynamics of the drug, mainly to assess the best doses for each group of patients (i.e. adult and elderly men). Effectiveness in a broad spectrum ED population is the subject of the second section of the review, principally reporting post-marketing company-independent results. Safety and tolerability are the key concerns of the third section, with a broad consideration of the most commonly reported adverse events. Special attention has been paid to the cardiovascular safety of the drug, chiefly outlining the positive and potentially protective cardiac effects of sildenafil. Moreover, the impact of sildenafil in special patient populations is considered, namely in men complaining of diabetes mellitus, depression, neurological disorders, renal failure and those who have undergone a radical prostatectomy. Sildenafil and the ageing male has been especially underlined. Finally, the review covers a few new potential applications of sildenafil in ED patients with regard to high-dose treatment and combination therapy. The review ends with several considerations regarding the direct and/or indirect impact of sildenafil over quality of life and quality of partnership.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997) · Urology · doi:10.1016/s0090-4295(97)00238-0 · Cited by 5,849
Oral Sildenafil in the Treatment of Erectile Dysfunction
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382001 · Cited by 2,120
(1991) · doi:10.1172/jci115266 · Cited by 429
Increased incidence of depressive symptoms in men with erectile dysfunction
Shabsigh, R., Klein, L. T., Seidman, S., Kaplan, S. A., Lehrhoff, B. J., & Ritter, J. S. (1998) · Urology · doi:10.1016/s0090-4295(98)00292-1 · Cited by 296
Baniel, J., Israilov, S., Segenreich, E., & Livne, P. M. (2001) · BJU International · doi:10.1046/j.1464-410x.2001.02254.x · Cited by 90
Quality of Partnership in Patients with Erectile Dysfunction after Sildenafil Treatment
Müller, M. J., Ruof, J., Graf-Morgenstern, M., Porst, H., & Benkert, O. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-14277 · Cited by 66
L‐Arginine reduces heart rate and improves hemodynamics in severe congestive heart failure
Bocchi, E. A., De Moraes, A. V., Esteves‐Filho, A., Bacal, F., Auler, J. O., Carmona, M. J., Bellotti, G., & Ramires, A. F. (2000) · Clinical Cardiology · doi:10.1002/clc.4960230314 · Cited by 45
Cited by
SHABSIGH, R., KAUFMAN, J. M., STEIDLE, C., & PADMA-NATHAN, H. (2004) · Journal of Urology · doi:10.1097/01.ju.0000132389.97804.d7 · Cited by 406
Contemporary treatment of sexual dysfunction: Reexamining the biopsychosocial model
Berry, M. D., & Berry, P. D. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12273 · Cited by 102
Turner, J. M., Russo, F., Deprest, J., Mol, B. W., & Kumar, S. (2022) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17163 · Cited by 26
Metadata
- Authors
- Salonia, A., Rigatti, P., & Montorsi, F.
- Venue
- Current Medical Research and Opinion
- Publisher
- Informa UK Limited
- Published
- 2003-01-01
- Volume
- 19
- Issue
- 4
- Pages
- 241-262
- ISSN
- 0300-7995 (ISSN-L)
- 1473-4877
- OpenAlex
- W2015054509
- Cited by
- 107
- References
- 7
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sildenafil in erectile dysfunction: a critical review. https://app.cochat.ai/papers/10.1185/030079903125001839
- The paper
- Salonia, A., Rigatti, P., & Montorsi, F. (2003). Sildenafil in erectile dysfunction: a critical review. Current Medical Research and Opinion. https://doi.org/10.1185/030079903125001839
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.